Zimmer BiometZBH
About: Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Employees: 17,000
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
74% more first-time investments, than exits
New positions opened: 146 | Existing positions closed: 84
50% more funds holding in top 10
Funds holding in top 10: 6 [Q3] → 9 (+3) [Q4]
4% more funds holding
Funds holding: 964 [Q3] → 1,005 (+41) [Q4]
3.47% more ownership
Funds ownership: 87.83% [Q3] → 91.3% (+3.47%) [Q4]
0% less capital invested
Capital invested by funds: $19.3B [Q3] → $19.2B (-$83.2M) [Q4]
20% less repeat investments, than reductions
Existing positions increased: 297 | Existing positions reduced: 370
26% less call options, than puts
Call options by funds: $62.5M | Put options by funds: $84M
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
6 analyst ratings
Truist Securities Richard Newitter 46% 1-year accuracy 22 / 48 met price target | 18%upside $113 | Hold Reiterated | 10 Feb 2025 |
Barclays Matt Miksic 44% 1-year accuracy 18 / 41 met price target | 16%upside $112 | Underweight Maintained | 10 Feb 2025 |
RBC Capital Shagun Singh 33% 1-year accuracy 22 / 66 met price target | 30%upside $125 | Outperform Maintained | 7 Feb 2025 |
Raymond James Jayson Bedford 39% 1-year accuracy 11 / 28 met price target | 24%upside $119 | Outperform Maintained | 7 Feb 2025 |
JMP Securities Andrew Boone 36% 1-year accuracy 32 / 90 met price target | 46%upside $140 | Market Outperform Reiterated | 7 Feb 2025 |
Financial journalist opinion
Based on 7 articles about ZBH published over the past 30 days
